Avenue Therapeutics, Inc. logo

Avenue Therapeutics, Inc.

Avenue Therapeutics, a Fortress Biotech Company, is focused on the development and commercialization of IV tramadol for the management of postoperative pain.

[stock_market_widget type=”leaderboard” template=”color-frame” color=”yellow” assets=”ATXI” api=”yf” style=”font-size: 15px”]

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.avenuetx.com
Disease Focus
Development Stage
STOCK CODENASDAQ: ATXI
Address
2 Gansevoort Street 9th Floor, NY 10014
New York
United States
Email
info@avenuetx.com
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/avenue-therapeutics” connections=”true” suffix=””]